David Roman
Stock Analyst at Goldman Sachs
(1.96)
# 3,031
Out of 4,896 analysts
44
Total ratings
37.5%
Success rate
-2.77%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMDA Omada Health | Initiates: Buy | $29 | $17.67 | +64.12% | 1 | Jul 1, 2025 | |
| HQY HealthEquity | Maintains: Neutral | $94 → $104 | $94.48 | +10.08% | 3 | Jun 4, 2025 | |
| BBNX Beta Bionics | Initiates: Neutral | $16 | $12.67 | +26.28% | 1 | May 30, 2025 | |
| PODD Insulet | Initiates: Buy | $380 | $289.32 | +31.34% | 1 | May 30, 2025 | |
| DOCS Doximity | Maintains: Neutral | $80 → $50 | $60.20 | -16.94% | 3 | May 21, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Neutral | $120 → $104 | $93.79 | +10.89% | 2 | May 6, 2025 | |
| TDOC Teladoc Health | Maintains: Buy | $13 → $10 | $8.32 | +20.19% | 4 | May 1, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $94 → $82 | $75.13 | +9.14% | 3 | May 1, 2025 | |
| KMTS Kestra Medical Technologies | Maintains: Neutral | $24 → $23 | $14.91 | +54.26% | 2 | Apr 16, 2025 | |
| ABT Abbott Laboratories | Maintains: Buy | $138 → $154 | $132.02 | +16.65% | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $24 | $15.59 | +53.94% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $63 → $71 | $73.80 | -3.79% | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $55 | $44.33 | +24.07% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $42 | $28.70 | +46.34% | 3 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $91 → $124 | $135.74 | -8.65% | 2 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $384 → $427 | $389.46 | +9.64% | 2 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $90 | $78.05 | +15.31% | 3 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $90 | $103.20 | -12.79% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $500 | $512.06 | -2.36% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $274 | $175.97 | +55.71% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $83 | $89.92 | -7.70% | 1 | May 30, 2024 |
Omada Health
Jul 1, 2025
Initiates: Buy
Price Target: $29
Current: $17.67
Upside: +64.12%
HealthEquity
Jun 4, 2025
Maintains: Neutral
Price Target: $94 → $104
Current: $94.48
Upside: +10.08%
Beta Bionics
May 30, 2025
Initiates: Neutral
Price Target: $16
Current: $12.67
Upside: +26.28%
Insulet
May 30, 2025
Initiates: Buy
Price Target: $380
Current: $289.32
Upside: +31.34%
Doximity
May 21, 2025
Maintains: Neutral
Price Target: $80 → $50
Current: $60.20
Upside: -16.94%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Neutral
Price Target: $120 → $104
Current: $93.79
Upside: +10.89%
Teladoc Health
May 1, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $8.32
Upside: +20.19%
GE HealthCare Technologies
May 1, 2025
Maintains: Buy
Price Target: $94 → $82
Current: $75.13
Upside: +9.14%
Kestra Medical Technologies
Apr 16, 2025
Maintains: Neutral
Price Target: $24 → $23
Current: $14.91
Upside: +54.26%
Abbott Laboratories
Mar 4, 2025
Maintains: Buy
Price Target: $138 → $154
Current: $132.02
Upside: +16.65%
Mar 3, 2025
Maintains: Neutral
Price Target: $42 → $24
Current: $15.59
Upside: +53.94%
Mar 3, 2025
Maintains: Sell
Price Target: $63 → $71
Current: $73.80
Upside: -3.79%
Mar 3, 2025
Maintains: Buy
Price Target: $64 → $55
Current: $44.33
Upside: +24.07%
Feb 26, 2025
Reinstates: Buy
Price Target: $42
Current: $28.70
Upside: +46.34%
Feb 24, 2025
Maintains: Neutral
Price Target: $91 → $124
Current: $135.74
Upside: -8.65%
Jan 30, 2025
Maintains: Neutral
Price Target: $384 → $427
Current: $389.46
Upside: +9.64%
Dec 5, 2024
Maintains: Buy
Price Target: $81 → $90
Current: $78.05
Upside: +15.31%
May 30, 2024
Initiates: Buy
Price Target: $90
Current: $103.20
Upside: -12.79%
May 30, 2024
Initiates: Buy
Price Target: $500
Current: $512.06
Upside: -2.36%
May 30, 2024
Initiates: Buy
Price Target: $274
Current: $175.97
Upside: +55.71%
May 30, 2024
Initiates: Sell
Price Target: $83
Current: $89.92
Upside: -7.70%